1. Home
  2. NVAX vs EXTR Comparison

NVAX vs EXTR Comparison

Compare NVAX & EXTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • EXTR
  • Stock Information
  • Founded
  • NVAX 1987
  • EXTR 1996
  • Country
  • NVAX United States
  • EXTR United States
  • Employees
  • NVAX N/A
  • EXTR N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • EXTR Telecommunications Equipment
  • Sector
  • NVAX Health Care
  • EXTR Telecommunications
  • Exchange
  • NVAX Nasdaq
  • EXTR Nasdaq
  • Market Cap
  • NVAX 1.3B
  • EXTR 2.4B
  • IPO Year
  • NVAX 1995
  • EXTR 1999
  • Fundamental
  • Price
  • NVAX $6.84
  • EXTR $17.29
  • Analyst Decision
  • NVAX Buy
  • EXTR Strong Buy
  • Analyst Count
  • NVAX 5
  • EXTR 7
  • Target Price
  • NVAX $16.60
  • EXTR $18.57
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • EXTR 1.2M
  • Earning Date
  • NVAX 08-07-2025
  • EXTR 08-06-2025
  • Dividend Yield
  • NVAX N/A
  • EXTR N/A
  • EPS Growth
  • NVAX N/A
  • EXTR N/A
  • EPS
  • NVAX 2.97
  • EXTR N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • EXTR $1,089,717,000.00
  • Revenue This Year
  • NVAX $56.85
  • EXTR $3.47
  • Revenue Next Year
  • NVAX N/A
  • EXTR $7.79
  • P/E Ratio
  • NVAX $2.30
  • EXTR N/A
  • Revenue Growth
  • NVAX 25.92
  • EXTR N/A
  • 52 Week Low
  • NVAX $5.01
  • EXTR $10.10
  • 52 Week High
  • NVAX $17.81
  • EXTR $19.24
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • EXTR 49.80
  • Support Level
  • NVAX $6.54
  • EXTR $17.83
  • Resistance Level
  • NVAX $7.20
  • EXTR $18.81
  • Average True Range (ATR)
  • NVAX 0.28
  • EXTR 0.45
  • MACD
  • NVAX 0.06
  • EXTR -0.12
  • Stochastic Oscillator
  • NVAX 66.36
  • EXTR 36.67

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides cloud networking solutions and industry services and support. Extreme designs, develops, and manufactures wired, wireless, and software-defined wide area-network (SD- WAN) infrastructure equipment, software and cloud-based network management solutions. The company's cloud solution is a single platform that offers unified network management of wireless access points, switches, and SD-WAN. The company operates in a single segment which develops and markets network infrastructure equipment. Roughly half of the firm's revenue is generated in the Americas, with the rest coming from Europe, the Middle East, Africa, and Asia-Pacific.

Share on Social Networks: